Summary
In a significant market movement during September 2021, Oviva was the subject of a vc funding. The transaction achieved a gross valuation of £58,128,459. Leading the round was F-Prime Capital, Earlybird, Temasek, AlbionVC, Eight Roads Ventures, Sofina, MedTech Innovation Partners - MTIP.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
F-Prime Capital
Lead Investor / Acquirer
Earlybird
Lead Investor / Acquirer
Temasek
Lead Investor / Acquirer
AlbionVC
Lead Investor / Acquirer
Eight Roads Ventures
Lead Investor / Acquirer
Sofina
Lead Investor / Acquirer
MedTech Innovation Partners - MTIP
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series C prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in